DNA-powered therapy halves 'bad' cholesterol, bypassing statins
TL;DR Summary
A DNA-based treatment using polypurine hairpins to silence PCSK9 lowers LDL cholesterol and boosts LDL receptors. In liver cells HpE9/HpE12 reduced PCSK9 RNA by up to 74% and protein by up to 87%; in transgenic mice a single injection cut PCSK9 by ~50% and cholesterol by ~47% within days, potentially offering a statin-free alternative with fewer side effects.
Reading Insights
Total Reads
0
Unique Readers
7
Time Saved
6 min
vs 7 min read
Condensed
96%
1,293 → 58 words
Want the full story? Read the original article
Read on ScienceDaily